ETF Holdings Breakdown of KRYS

News associated with KRYS

Krystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Lifted by GAMMA Investing LLC

GAMMA Investing LLC boosted its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 50,249.4% during the first quarter, HoldingsChannel.com reports. The firm owned 121,342 shares of the company’s stock after acquiring an additional 121,101 shares during the period. GAMMA Investing LLC’s holdings in Krystal Biotech were worth $21,878,000 as of its […] - 2025-06-06 09:16:55

Janus Henderson Group PLC Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS)

Janus Henderson Group PLC raised its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 16.1% during the fourth quarter, HoldingsChannel reports. The firm owned 10,071 shares of the company’s stock after purchasing an additional 1,400 shares during the quarter. Janus Henderson Group PLC’s holdings in Krystal Biotech were worth $1,579,000 as […] - 2025-05-23 08:19:08

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $2.39 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. trimmed its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,205 shares of the company’s stock after selling 181 shares during the period. […] - 2025-05-22 09:30:46

Deutsche Bank AG Has $3.97 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)

Deutsche Bank AG boosted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 62.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 25,361 shares of the company’s stock after acquiring an additional 9,750 shares during the quarter. Deutsche […] - 2025-05-20 08:14:53

Citigroup Has Lowered Expectations for Krystal Biotech (NASDAQ:KRYS) Stock Price

Krystal Biotech (NASDAQ:KRYS – Free Report) had its target price decreased by Citigroup from $215.00 to $155.00 in a research note published on Friday morning,Benzinga reports. Citigroup currently has a neutral rating on the stock. A number of other brokerages have also recently issued reports on KRYS. HC Wainwright reissued a “buy” rating and issued […] - 2025-05-19 05:46:51

Krystal Biotech (NASDAQ:KRYS) Hits New 52-Week Low on Disappointing Earnings

Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) hit a new 52-week low during trading on Tuesday following a weaker than expected earnings announcement. The company traded as low as $137.00 and last traded at $139.47, with a volume of 283299 shares traded. The stock had previously closed at $162.29. The company reported […] - 2025-05-08 05:24:46

Commit To Purchase Krystal Biotech At $150, Earn 16.3% Annualized Using Options

Investors considering a purchase of Krystal Biotech Inc (Symbol: KRYS) stock, but cautious about paying the going market price of $169.11/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in parti - 2025-04-30 15:44:33

102,061 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Purchased by Raymond James Financial Inc.

Raymond James Financial Inc. purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 102,061 shares of the company’s stock, valued at approximately $15,989,000. Raymond James Financial Inc. owned approximately 0.35% […] - 2025-04-22 08:45:14

Bank of Montreal Can Increases Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)

Bank of Montreal Can grew its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 5.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 3,325 shares of the company’s stock after buying an additional 179 shares during the period. Bank of Montreal Can’s holdings in Krystal Biotech were worth $521,000 […] - 2025-04-22 07:50:52

Krystal Biotech, Inc. (NASDAQ:KRYS) Position Reduced by Invesco Ltd.

Invesco Ltd. reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 24.7% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 275,195 shares of the company’s stock after selling 90,356 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-17 08:57:00

Federated Hermes Inc. Has $2.04 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)

Federated Hermes Inc. raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 13,048 shares of the company’s stock after purchasing an additional 229 shares during the […] - 2025-04-14 09:20:51

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 18.7% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 151,835 shares of the company’s stock after buying an additional 23,934 shares during the period. JPMorgan Chase & Co.’s holdings in Krystal Biotech were worth $23,786,000 as of […] - 2025-04-10 08:07:14

Mitsubishi UFJ Asset Management Co. Ltd. Cuts Position in Krystal Biotech, Inc. (NASDAQ:KRYS)

Mitsubishi UFJ Asset Management Co. Ltd. decreased its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 13.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,367 shares of the company’s stock after selling 210 shares during the period. Mitsubishi UFJ […] - 2025-04-04 08:12:57

Sei Investments Co. Sells 13,085 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)

Sei Investments Co. cut its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 38.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,164 shares of the company’s stock after selling 13,085 shares during the quarter. Sei Investments Co.’s holdings in Krystal […] - 2025-04-04 07:38:46

4,300 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by KLP Kapitalforvaltning AS

KLP Kapitalforvaltning AS acquired a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,300 shares of the company’s stock, valued at approximately $674,000. Other institutional investors also […] - 2025-04-02 08:12:54

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Bought by Prudential Financial Inc.

Prudential Financial Inc. raised its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 8.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,193 shares of the company’s stock after purchasing an additional 3,254 shares during the quarter. Prudential […] - 2025-03-31 08:22:46

Thrivent Financial for Lutherans Sells 291 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)

Thrivent Financial for Lutherans lessened its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 1.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,563 shares of the company’s stock after selling 291 shares during the quarter. Thrivent Financial […] - 2025-03-27 07:52:53

Cibc World Markets Corp Buys New Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)

Cibc World Markets Corp purchased a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,321 shares of the company’s stock, valued at approximately $364,000. Other hedge funds and […] - 2025-03-25 08:08:46

Zurcher Kantonalbank Zurich Cantonalbank Raises Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)

Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 31.2% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 6,054 shares of the company’s stock after acquiring an additional 1,440 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings […] - 2025-03-21 08:45:13

102,061 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by Raymond James Financial Inc.

Raymond James Financial Inc. bought a new position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 102,061 shares of the company’s stock, valued at approximately $15,989,000. A number of […] - 2025-03-19 07:59:08

Arizona State Retirement System Grows Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)

Arizona State Retirement System boosted its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 8.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,242 shares of the company’s stock after purchasing an additional 487 shares during the […] - 2025-03-14 08:12:51

Victory Capital Management Inc. Reduces Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)

Victory Capital Management Inc. cut its holdings in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 17.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 81,328 shares of the company’s stock after selling 16,957 shares during the period. Victory Capital […] - 2025-03-13 08:32:54

Krystal Biotech, Inc. (NASDAQ:KRYS) Shares Sold by Keybank National Association OH

Keybank National Association OH cut its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 20.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 1,309 shares of the company’s stock after selling 340 shares during the period. Keybank National Association OH’s holdings in Krystal Biotech were worth $205,000 as of […] - 2025-03-12 07:52:49

Krystal Biotech, Inc. (NASDAQ:KRYS) Sees Significant Decrease in Short Interest

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 31st, there was short interest totalling 3,010,000 shares, a decline of 7.4% from the January 15th total of 3,250,000 shares. Based on an average trading volume of 262,600 shares, the short-interest ratio […] - 2025-02-19 08:48:54

Mirae Asset Global Investments Co. Ltd. Sells 81 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)

Mirae Asset Global Investments Co. Ltd. lessened its stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 7.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 958 shares of the company’s stock after selling 81 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Krystal Biotech were worth […] - 2025-02-14 08:30:56

3,500 Shares in Krystal Biotech, Inc. (NASDAQ:KRYS) Bought by Entropy Technologies LP

Entropy Technologies LP purchased a new stake in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 3,500 shares of the company’s stock, valued at approximately $548,000. Other institutional investors […] - 2025-02-13 10:12:51

KRYS institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	14,716	USD 2,098,207 0.1%
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	2,249	USD 320,662
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	14,420	USD 2,056,004
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	14,420	USD 2,056,004
2025-06-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	81	USD 11,549
Total =		45,886	USD 6,542,426

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer